ARCHIMED Acquires Majority Stake in Germany's Zyto Group

ARCHIMED Acquires Majority Stake in Cube (Cube Biotech)

November 3, 2021

Biotechnology

Transatlantic healthcare private equity firm ARCHIMED has purchased a majority stake in Monheim, Germany-based Cube (Cube Biotech), a specialist provider of high-purity, stable membrane proteins for drug discovery. ARCHIMED will support Cube's US market expansion and broaden its product and service offering organically and via acquisitions while Cube's founding management remain significant shareholders and continue to lead the business.

ARCHIMED Acquires Majority Stake in Cardioline

November 17, 2021

Medical Devices

Trans-Atlantic private equity firm ARCHIMED has acquired a majority stake in Cardioline, a Trento, Italy-based maker of cardiology devices and Europe's largest provider of cardiology-focused telemedicine. The investment, made through ARCHIMED's MED III Fund, will support Cardioline's product and software development, international expansion and potential add-on M&A while founders retain a significant minority stake and remain in management.

ARCHIMED Acquires ZimVie

October 20, 2025

Medical Devices

ARCHIMED MedTech, via its MED Platform II fund, has taken NASDAQ-listed ZimVie private in a $19.00-per-share cash transaction valuing the company at an enterprise value of approximately $730 million. Headquartered in Palm Beach Gardens, Florida, ZimVie is a global dental technology company (implants, regenerative biomaterials and digital dentistry) with ~1,700 employees; ARCHIMED plans to accelerate growth, invest in new product development and pursue selective complementary acquisitions.

ARCHIMED Acquires Majority Stake in Title21 Health Solutions

July 12, 2022

Healthcare Services

ARCHIMED has acquired a majority stake in Phoenix-based Title21 Health Solutions through its MED III fund, with founders Lynn Fischer and Kent Kirimli retaining a significant minority. Title21 is an end-to-end software provider for cell and gene therapy labs; ARCHIMED plans to accelerate R&D, international expansion (Europe and Asia) and further digitization of the sector.

ARCHIMED (MED Platform I) Acquires Majority Stake in CARSO

December 16, 2021

Healthcare Services

Transatlantic healthcare private equity firm ARCHIMED, via its MED Platform I fund and in partnership with CAPZA Expansion and Siparex, has acquired a majority stake in Lyon-based CARSO, a leader in purity and analytical testing for pharma, healthcare, environmental and food sectors. The deal (debt provided by Tikehau Capital and several banks) will support CARSO's internationalization and service-range expansion as the group aims to more than double current annual revenues (above €200 million).

ARCHIMED Acquires 75% Stake in ActiGraph

May 18, 2020

Medical Devices

ARCHIMED (ArchiMed) has acquired a 75% stake in ActiGraph in an all-equity transaction, with management retaining 10% and other historic shareholders keeping 15%. The investment will fund ActiGraph's expansion into the regulated drug-development and clinical-trials market, accelerating product, regulatory and commercial capabilities; financial terms were not disclosed.